Effects of a psychosocial intervention on survival among patients with stage I breast and prostate cancer: A matched case-control study

Alternative Therapies in Health and Medicine

Volumn 5, Issue 3, 1999, Pages 49-55

  Shrock, Dean ^c   Palmer, Raymond F ^a   Taylor, Bonnie ^b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BREAST TUMOR; CASE CONTROL STUDY; CLINICAL TRIAL; FEMALE; HUMAN; MALE; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PATIENT EDUCATION; PROSTATE TUMOR; PSYCHOLOGICAL ASPECT; SOCIAL SUPPORT; SURVIVAL;

AGED; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT EDUCATION; PROSTATIC NEOPLASMS; SOCIAL SUPPORT; SURVIVAL ANALYSIS;

EID: 0033126308     PISSN: 10786791     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. LeShan L. A basic psychological orientation apparently associated with malignant disease. Psychiatr Q. 1961;36:314.
2. LeShan L. An emotional life-history pattern associated with neoplastic disease. Ann N Y Acad Sci. 1966;125:780-793.
3. Derogatis LR, Abeloff MD, Melisaratos N. Psychological coping mechanisms and survival time in metastatic breast cancer. JAMA. 1979;242:1504-1508.
4. Greer S, Morris T, Pettingale KW, Haybittle JL. Psychological response to breast cancer and 15-year outcome. Lancet. 1990;335:49-50.
5. Greer S, Morris T, Pettingale KW. Psychological response to breast cancer: effect on outcome. Lancet. 1979;2(8146):785-787.
6. Pettingale KW, Morris T, Greer S, Haybittle JL. Mental attitudes to cancer: an additional prognostic factor. Lancet. 1985;1(8431):750.
7. Bahnson CB, Bahnson MB. Role of the ego defenses: denial and repression in the etiology of malignant neoplasm. Ann N Y Acad Sci. 1966;123:827-845.
8. Schmale AH Jr, Iker HP. The psychological setting of uterine cervical cancer. Ann N Y Acad Sci. 1966;125:807-813.
9. Achterberg J, Lawlis GF, Simonton OC, Matthews-Simonton S. Psychological factors and blood chemistries as disease outcome predictors for cancer patients. Multivariate Exp Clin Res. 1977;3:107-122.
10. Rogentine GN Jr, VanKammen DP, Fox BH, et al. Psychological factors in the prognosis of malignant melanoma: a prospective study. Psychosom Med. 1979;41:647-655.
11. Grossarth-Maticek R, Frentzel-Beyme R, Becker N. Cancer risks associated with life events and conflicts solution. Cancer Detect Prev. 1984;7:201-209.
12. Eysenck HJ. Personality, cancer and cardiovascular disease: a causal analysis. Pers Individual Differences. 1985;6:535-556.
13. Eysenck HJ. Personality as a predictor of cancer and cardiovascular disease, and the application of behaviour therapy in prophylaxis. Eur J Psychiatry. 1987;1:29-41.
14. Temoshok L, Heller BW, Sagebiel RW, et al. The relationship of psychosocial factors to prognostic indicators in cutaneous malignant melanoma. J Psychosom Res. 1985;29:139-153.
15. Bremond A, Kune GA, Bahnson CB. Psychosomatic factors in breast cancer patients: results of a case control study. J Pychosom Obstet Gynaecol. 1986;5:127-136.
16. Levy S. Behavior and Cancer: Life-style and Psychosocial Factors in the Initiation and Progression of Cancer. San Francisco, Calif: Jossey-Bass; 1985.
17. Temoshok L, Dreher H. The Type C Connection: The Behavioral Links to Cancer and Your Health. New York, NY: Random House; 1992.
18. Dreher H. The scientific and moral imperative for broad-based psychosocial interventions for cancer. Advances. 1997;13:38-49.
19. Simonton OC, Matthews-Simonton S. Cancer and stress: counseling the cancer patient. Med J Aust. 1981;1:679-683.
20. Simonton OC, Matthews-Simonton S, Sparks TF. Psychological intervention in the treatment of cancer. Psychosomatics. 1980;21(3):226-233.
21. Morgenstern H, Gellert GA, Walter SD, Ostfeld AM, Siegel B. The impact of a psychosocial support program on survival with breast cancer: the importance of selection bias in program evaluation. J Chronic Dis. 1984;37:273-282.
22. Gellert GA, Maxwell RM, Siegel BS. Survival of breast cancer patients receiving adjunctive psychosocial support therapy. J Clin Oncol. 1993;11:66-69.
23. Spiegel D, Bloom J, Kraemer HC, Gottheil E. Effect of psychosocial treatment on survival of patients with metastatic breast cancer. Lancet. 1989;2:888-891.
24. Fawzy FI, Fawzy NW, Hyun CS, et al. Effects of an early structured psychiatric intervention, coping, and affective state on recurrence and survival 6 years later. Arch Gen Psychiatry. 1993;50:681-689.
25. Kogon MM, Biswas A, Pearl D, Carlson RW, Spiegel D. Effects of medical and psychotherapeutic treatment on the survival of women with metastatic breast carcinoma. Cancer. 1997;80:225-230.
26. Studies of counselings' impact on survival challenged. Oncol News Int. 1997;6:55.
27. Jessup JM, Hundahl SA, Winchester DP, Menck HR, eds. National Cancer Data Base Annual Hospital Report. Chicago, Ill: American College of Surgeons; 1996.
28. Richardson JL, Shelton DR, Krailo M, Levine AM. The effect of compliance with treatment on survival among patients with hematologic malignancies. J Clin Oncol. 1990;8:356-364.
29. Ilnyckyj A, Farber J, Cheang MC, Weinerman BH. A randomized controlled trial of psychotherapeutic intervention in cancer patients. Ann R Coll Phys Surg Can. 1994;27:93-96.
30. Linn MW, Linn BS, Harris R. Effects of counseling for late-stage cancer patients. Cancer. 1982;49:1048-1055.
31. Fawzy FI, Fawzy NW, Arndt LA, Pasnau RO. Critical review of psychosocial interventions in cancer cue. Arch Gen Psychiatry. 1995;52:100-113.
32. Reele BL. Effect of counseling on quality of life for individuals with cancer and their families. Cancer Nurs. 1994;17:101-112.
33. Fox BH. The role of psychological factors in cancer incidence and prognosis. Oncology. 1995;9:245-255.
34. Block KI. The role of the self in healthy cancer survivorship: a view from the front lines of treating cancer. Advances. 1997;13:6-26.
35. Simonton OC, Matthews-Simonton S, Creighton J. Getting Well Again. Los Angeles, Calif: JP Tarcher; 1978.
36. Matthews-Simonton S. The Healing Family. New York, NY: Bantam Books; 1984.
37. SAS Institute Inc. SAS/STAT User's Guide: Version 6. 4th ed. Vol 1. Cary, NC: SAS Institute Inc; 1989.
38. Kalbfleisch JD, Prentice RL. The Statistical Analysis of Failure Time Data. New York, NY: John Wiley & Sons; 1980.
39. Cox DR, Oakes D. Analysis of Survival Data. London, England: Chapman & Hall; 1984.
40. Turner JA, Deyo RA, Loeser JD, VonKorff M, Fordyce WE. The importance of placebo effects in pain treatment and research JAMA. 1994;271:1609-1614.
41. Andersen BL, Kiecolt-Glaser JK, Glaser R. A biobehavioral model of cancer stress and disease course. Am Pychol. 1994;49:389-404.
42. Kennedy S, Kiecolt-Glaser JK, Glaser R. Immunological consequences of acute and chronic stressors: mediating role of interpersonal relationships. Br J Med Psychol. 1988;61:77-85.
43. Levy SM, Herberman RB, Maluish M, Schlein B, Lippman M. Prognostic risk assessment in primary breast cancer by behavioral and immunological parameters. Health Pychol. 1985;4:99-113.
44. Futterman AD, Kemeny ME, Shapiro D, Fahey JL. Immunological and physiological changes associated with induced positive and negative mood. Psychosom Med. 1994;56:499-511.
45. Gross J. Emotional expression in cancer onset and progression. Soc Sci Med. 1989;12:1239-1248.
46. Temoshok L. Biopsychosocial studies on cutaneous malignant melanoma: psychosocial factors associated with prognostic indicators, progression, psychophysiology, and tumor-host response. Soc Sci Med. 1985;20:833-840.
47. Temoshok L. Personality, coping style, emotion, and cancer: towards an integrative model. Cancer Surv. 1987;6:545-567.
48. Pert CB, Ruff MR, Weber RJ, Herkenham M. Neuropeptides and their receptors: a psychosomatic network. J Immunol. 1985;135(suppl 2):820s-826s.
49. Pert CB. Paper presented at: A Question of Hope; October 1995; Bristol, United Kingdom.
50. Wood C. Is hope a treatment for cancer? Advances. 1996;12:67-71.
51. Levy SM, Herberman RB, Whiteseide H, Kirkwood J, McFeeley S. Perceived social support and tumor estrogen/progesterone receptor status as predictors of natural killer cell activity in breast cancer patients. Psychosom Med. 1990;52:73-85.
52. Levy S, Herberman R, Lippman M, D'Angelo T. Correlation of stress factors with sustained depression of natural killer cell activity and predicted prognosis in patients with breast cancer. J Clin Oncol 1987;5:348-353.
53. Cacioppo J. Social neuroscience: autonomic, neuroendocrine and immune responses to stress. Psychophysiology. 1994;31:113-128.
54. Dossey L. Meaning and Medicine. New York, NY: Bantam Books; 1991.
55. Berland W. Unexpected cancer recovery: why patients believe they survive. Advances. 1995;4:5-19.
56. Pert CB. Molecules of Emotion: Why You Feel the Way You Feel. New York, NY: Scribner; 1997.
57. Ornish D. Dr Dean Ornish's Program for Reversing Heart Disease. New York, NY: Ivy Books; 1996.
58. Fisher B, Costantino J, Redmond C, et al. Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. N Engl J Med. 1993;328:1581-1586.